55
Participants
Start Date
Not specified
Study Completion Date
January 31, 2005
Abacavir sulfate
Nelfinavir mesylate
Nevirapine
Lamivudine
Stavudine
Zidovudine
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology, Baltimore
Children's Hosp. of the King's Daughters, Infectious Disease, Norfolk
Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy, Gainesville
Texas Children's Hosp. CRS, Houston
The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore
Tulane/LSU Maternal/Child CRS, New Orleans
BMC, Div. of Ped Infectious Diseases, Boston
Baystate Health, Baystate Med. Ctr., Springfield
WNE Maternal Pediatric Adolescent AIDS CRS, Worcester
Univ. of Mississippi Med. Ctr Children's Hosp., Detroit
Nyu Ny Nichd Crs, New York
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH